Viewing nowTelmisartan 80 mg Tablets
Telmisartan 80mg
Tablet · Prescription medication
Green Cross Corp.

MFDS item code 201003094 · Notified 2010.04.27 · Insurance code 644501750
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication helps control blood pressure in patients with essential hypertension. It also reduces the likelihood of developing cardiovascular diseases in high-risk patients aged 55 and older. Specifically, it is used to lower the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in those with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or those with organ damage due to diabetes. This efficacy significantly contributes to improving the cardiovascular health of patients.
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. When this medicine is administered concomitantly with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication may cause serious harm to both the fetus and newborn during pregnancy, so discontinuation is necessary if pregnancy is confirmed. It should not be used in women who are pregnant or breastfeeding, patients with severe liver impairment, a history of certain angioedema, or those with diabetes or severe kidney impairment. Elderly patients or those with hyperkalemia, liver disease, cardiovascular disease, gastrointestinal disorders, or renovascular hypertension should use this medication cautiously and monitor their condition carefully. During treatment, various adverse reactions such as blood pressure reduction, hyperkalemia, renal dysfunction, angioedema, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, and any symptoms should be discussed with a physician immediately. Patients with impaired renal function should have their serum potassium and creatinine levels monitored regularly, and any deficiencies in blood volume or sodium should be corrected before administration to prevent symptoms of hypotension. When used with other antihypertensive medications or certain drugs, interactions may occur, so patients should inform their physician or pharmacist and monitor carefully. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are advised to discontinue breastfeeding while taking this medication. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established. In elderly patients, caution should be exercised to avoid excessive blood pressure reduction, and consideration should be given to the risk of dizziness or fainting when driving or operating hazardous machinery. In the case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur, requiring immediate emergency treatment and frequent checks of blood pressure and blood tests.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White or off-white oval tablets
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Green Cross Corp.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.